In this issue:
MS trajectory after menopause
Contribution of RAW & PIRA to EDSS in different time periods
Extended interval dosing of ocrelizumab
MOG-Ab in a first demyelinating event
Alcohol consumption & disability accumulation
DOT-MS: Discontinuation of first-line DMT in long-term stable MS
Real-world infection risks with DMTs
Hypertension with teriflunomide vs.dimethyl fumarate
Smartphone gaming tool to monitor cognitive function in MS
Aspirin or acetaminophen to reduce overheating during exercise
Please login below to download this issue (PDF)